Antiviral effect of sinefungin on in vitro growth of feline herpesvirus type 1

J Antibiot (Tokyo). 2019 Dec;72(12):981-985. doi: 10.1038/s41429-019-0234-4. Epub 2019 Sep 18.

Abstract

Feline herpesvirus type 1 (FHV-1) causes a potentially fatal disease in cats. Through the use of virus inhibition and cytotoxicity assays, sinefungin, a nucleoside antibiotic, was assessed for its potential to inhibit the growth of FHV-1. Sinefungin inhibited in vitro growth of FHV-1 most significantly over other animal viruses, such as feline infectious peritonitis virus, equine herpesvirus, pseudorabies virus and feline calicivirus. Our results revealed that sinefungin specifically suppressed the replication of FHV-1 after its adsorption to the host feline kidney cells in a dose-dependent manner without obvious cytotoxicity to the host cells. This antibiotic can potentially offer a highly effective treatment for animals infected with FHV-1, providing alternative medication to currently available antiviral therapies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / pharmacology
  • Adenosine / toxicity
  • Animals
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / toxicity
  • Calicivirus, Feline / drug effects
  • Cat Diseases / drug therapy
  • Cats
  • Cell Line
  • Coronavirus, Feline / drug effects
  • Dose-Response Relationship, Drug
  • Herpesviridae Infections / drug therapy
  • Herpesviridae Infections / veterinary
  • Herpesvirus 1, Equid / drug effects
  • Herpesvirus 1, Suid / drug effects
  • Horses
  • Kidney / cytology
  • Kidney / virology
  • Toxicity Tests
  • Varicellovirus / drug effects*

Substances

  • Antiviral Agents
  • Adenosine
  • sinefungin

Supplementary concepts

  • Felid alphaherpesvirus 1